Published in Lab Business Week, November 12th, 2006
Trevi Health Ventures led the round, which included WHI Group and select private investors. In conjunction with the financing, Andrew Fink, managing director of Trevi, and Steven Kaye, an investor in Trevi, will join AGI's board of directors.
"We are very pleased with this strong interest in our program for commercialization of our technology," said Daniel B. Yarosh, PhD, AGI Dermatics' president and CEO. "Enthusiasm for this financing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.